These changes were made to perform diagnosis earlier: recent studies have shown that patients with JAK2 mutated thrombocytosis and moderately high HCT have increased thrombotic risk (“masked” PV), regardless of sex [36]. Here, JAK2 is linked to acquired polycythemia vera.